These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
What is GLP-2?
Key Research
Specifications
Property | Details |
---|---|
CAS Number | 2023788-19-2 |
Chemical Name | Dual GIP/GLP-1 receptor agonist peptide |
PubChem CID | 156588324 |
Molecular Formula | C225H348N48O68 (free base) |
Molecular Weight | ≈ 4,813.5 g/mol (free base) |
Physical Appearance | White to off-white lyophilized powder |
Form | Synthetic polypeptide (dual GLP-1/GIP receptor agonist) |
Container | 3 mL Type I glass vial, bromobutyl rubber stopper, aluminum flip-off seal (net content: 5 mg |
Purity | ≥99% verified by HPLC & MS (batch COA via on-vial QR) |
Solubility | Soluble in sterile water; for concentrated stocks, pre-wet with ≤0.1–5% acetic acid and gently agitate. Consider 0.05–0.1% carrier protein to minimize adsorption; 0.22 µm filter-sterilize if required. |
Intended Use | Laboratory research only (RUO). Not for human or animal use. |
Molecular Structure

FAQ
How much is in each vial?
Does it come with instructions?
What other supplies are needed?
How long does a vial last?
Is Tirzepatide FDA approved?
Which in-vitro or experimental assays is Tirzepatide commonly used in?
References
- Jastreboff, A. M., et al. “Tirzepatide once weekly for the treatment of obesity.” New England Journal of Medicine 387(3), 2022, 205–216 [Link]
- Frias, J. P., et al. “Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes.” New England Journal of Medicine 385(6), 2021, 503–515. [Link]
- Ludvik, B., Giorgino, F., Jodar, E., et al. “Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in type 2 diabetes (SURPASS-3).” Lancet 398(10300), 2021, 583–598. [Link]
- Del Prato, S., Kahn, S. E., Pavo, I., et al. “Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4).” Lancet 398(10313), 2021, 1811–1824. [Link]
- Cosentino, F., et al. “Cardiometabolic effects of tirzepatide in type 2 diabetes: A review of the SURPASS trials.” Diabetes Therapy 13(6), 2022, 1253–1272. [Link]
Why Buy from USA Peptides Direct
- USA Made
- Same-Day Shipping (Mon–Fri, on in-stock items)
- GMP-Standard lyophilization, documented & traceable
- 24/7 Support
- Price Match Guarantee
- Batch Tracking with QR Code Verification
- 3rd-Party U.S. Lab Testing — purity, quantity, endotoxin
- Cold-Chain Shipping — Always (no paid upgrade)
- All Major Payments Accepted
- Text & Email Order Updates
- 2-Day FedEx/UPS Shipping Standard
- Cheapest Overnight Rates
- Large Variety of Peptides & Bioregulators
Quality, Storage & Handling
Each lot is confirmed by HPLC (purity) and MS (identity); QR on the vial links to the batch COA. Independent U.S. labs verify purity, quantity, and endotoxin.
- Storage (lyophilized): −20 °C long-term or 2–8 °C short-term; keep desiccated and protected from light.
- After reconstitution: Use neutral, oxygen-poor buffer when possible; aliquot and store at ≤−20 °C; avoid repeated freeze–thaw.
- Working solutions: Prepare fresh; minimize exposure to light/alkaline pH to reduce degradation.
Shipping
Ships in validated cold-chain packaging. In-stock orders placed before the daily cutoff dispatch the same day. 2-Day FedEx/UPS is standard, with overnight options available. Automated text/email updates included.
Compliance & Research Use Only Disclaimer
For laboratory research only. All articles are product information provided on this website are for informational and educational purposes only. Not a drug, cosmetic, food, or household chemical. Not for human or animal use, diagnostic, or therapeutic applications. Buyers warrant they are qualified to handle RUO materials under applicable laws and institutional guidelines. COAs available via QR or upon request.